Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements

Hepatology

Volumn 27, Issue 1, 1998, Pages 160-165

  Suzuki, M ^a   Singh, R N ^a   Crystal, R G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; GENE INDUCTION; GENE THERAPY; GENE TRANSFER; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE;

EID: 0031972495     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270125     Document Type: Article

References (40)

1. 1 Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995 ; 270: 404–410. MEDLINE
2. 2 Brenner MK. Human somatic gene therapy: progress and problems. J Intern Med 1995 ; 237: 229–239. MEDLINE
3. 3 Roesler WJ, Vandenbark GR, Hanson RW. Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 1988 ; 263: 9063–9066. MEDLINE
4. 4 Suzuki M, Singh NR, Crystal RG. Regulatable promoters for use in gene therapy applications: modification of the 5′‐flanking region of the CFTR gene with multiple cAMP response elements to support basal, low‐level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP. Hum Gene Ther 1996 ; 7: 1883–1893. MEDLINE
5. 5 Yoshimura K, Nakamura H, Trapnell BC, Dalemans W, Pavirani A, Lecocq J‐P, Crystal RG. The cystic fibrosis gene has a “housekeeping”‐type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem 1991 ; 266: 9140–9144. MEDLINE
6. 6 Widdicombe JH. Cystic fibrosis and β‐adrenergic response of airway epithelial cell cultures. Am J Physiol 1986 ; 251: R818–R822. MEDLINE
7. 7 Seamon KB, Daly JW. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 1986 ; 20: 1–150. MEDLINE
8. 8 Corvera S, Huerta‐Bahena J, Pelton JT, Hruby VJ, Trivedi D, Garcia‐Sainz JA. Metabolic effects and cyclic amp levels produced by glucagon, (1‐n alpha‐trinitrophenylhistidine,12‐homoarginine)glucagon and forskolin in isolated rat hepatocytes. Biochim Biophys Acta 1984 ; 804: 434–441. MEDLINE
9. 9 Pushpendran CK, Corvera S, Garcia‐Sainz JA. Forskolin effects on the beta‐adrenergic responsiveness of rat hepatocytes. Biochem Pharmacol 1984 ; 33: 3099–3101. MEDLINE
10. 10 Seglen PO. Hepatocyte suspensions and cultures as tools in experimental carcinogenesis. J Toxicol Environ Health 1979 ; 5: 551–560. MEDLINE
11. 11 Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, et al. Adenovirus‐mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992 ; 1: 372–378. MEDLINE
12. 12 Wolff G, Mastrangeli A, Heinflink M, Falck‐Pedersen E, Gershengorn MC, Crystal RG. Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by trh. Nat Genet 1996 ; 12: 274–279. MEDLINE
13. 13 de Wet JR, Wood KV, De Luca M, Helinski DR, Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987 ; 7: 725–737. MEDLINE
14. 14 McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988 ; 163: 614–617. MEDLINE
15. 15 Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH. The rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by dna‐mediated transfection. Proc Natl Acad Sci U S A 1982 ; 79: 6777–6781. MEDLINE
16. 16 Graham FL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973 ; 52: 456–467. MEDLINE
17. 17 Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992 ; 68: 143–155. MEDLINE
18. 18 Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Paakko PK, et al. Adenovirus‐mediated transfer of a recombinant alpha 1‐antitrypsin gene to the lung epithelium in vivo. Science 1991 ; 252: 431–434. MEDLINE
19. 19 Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977 ; 36: 59–72. MEDLINE
20. 20 Meyer RB, Miller JP. Analogs of cyclic amp and cyclic gmp: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci 1974 ; 14: 1019–1040. MEDLINE
21. 21 Herz J, Gerard RD. Adenovirus‐mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A 1993 ; 90: 2812–2818. MEDLINE
22. 22 Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 1995 ; 2: 151–155. MEDLINE
23. 23 Chang AG, Wu GY. Gene therapy: applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994 ; 106: 1076–1084. MEDLINE
24. 24 Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long‐term expression. Proc Natl Acad Sci U S A 1995 ; 92: 1401–1405. MEDLINE
25. 25 Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus‐mediated gene delivery. J Clin Invest 1993 ; 92: 883–893. MEDLINE
26. 26 Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci U S A 1994 ; 91: 2353–2357. MEDLINE
27. 27 Kay MA, Li Q, Liu TJ, Leland F, Toman C, Finegold M, Woo SL. Hepatic gene therapy: persistent expression of human alpha 1‐antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 1992 ; 3: 641–647. MEDLINE
28. 28 Kolodka TM, Finegold M, Moss L, Woo SL. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci U S A 1995 ; 92: 3293–3297. MEDLINE
29. 29 Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford‐Perricaudet LD, Wilson JM. In vivo correction of low density lipoprotein receptor deficiency in the watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994 ; 269: 13695–13702. MEDLINE
30. 30 Ohwada A, Hirschowitz EA, Crystal RG. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5‐fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum Gene Ther 1996 ; 7: 1567–1576. MEDLINE
31. 31 Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993 ; 5: 397–402. MEDLINE
32. 32 Spady DK, Cuthbert JA, Willard MN, Meidell RS. Adenovirus‐mediated transfer of a gene encoding cholesterol 7 alpha‐hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 1995 ; 96: 700–709. MEDLINE
33. 33 Stratford‐Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme‐encoding gene using a human adenovirus vector. Hum Gene Ther 1990 ; 1: 241–256. MEDLINE
34. 34 Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM. Prolonged metabolic correction in adult ornithine transcarbamylase‐deficient mice with adenoviral vectors. J Biol Chem 1996 ; 271: 3639–3646. MEDLINE
35. 35 Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, et al. A controlled study of adenoviral‐vector–mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995 ; 333: 823–831. MEDLINE
36. 36 Worgall S, Wolff G, Falck‐Pedersen E, Crystal RG. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 1997 ; 8: 37–44. MEDLINE
37. 37 Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1‐deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994 ; 91: 4407–4411. MEDLINE
38. 38 Zsengeller ZK, Wert SE, Hull WM, Hu X, Yei S, Trapnell BC, Whitsett JA. Persistence of replication‐deficient adenovirus‐mediated gene transfer in lungs of immune‐deficient (nu/nu) mice. Hum Gene Ther 1995 ; 6: 457–467. MEDLINE
39. 39 Lee MG, Abina MA, Haddada H, Perricaudet M. The constitutive expression of the immunomodulatory gp19k protein in E1‐, E3‐adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther 1995 ; 2: 256–262. MEDLINE
40. 40 Smith TAG, White BD, Gardner JM, Kaleko M, McClelland A. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther 1996 ; 3: 496–502. MEDLINE